Loading...
Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again
Epratuzumab (anti-CD22) is a humanized monoclonal antibody that recognizes a pan-B-cell marker. It potentially downregulates B cell activity through negative signaling, as well as depleting B cells moderately. The uncontrolled series discussed by Dörner and colleagues in this issue of Arthritis Rese...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1526641/ https://ncbi.nlm.nih.gov/pubmed/16732895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1967 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|